News

Google’s Secret Moonshot Project Gears Up For Human Trail Of AI-Designed Drugs
Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The hitherto lesser-known Google subsidiary aims to revolutionize drug development by using advanced AI to create medicines more quickly, affordably, and accurately than traditional methods.
Alphabet’s Isomorphic Labs has grand ambitions to ‘solve all diseases’ with AI. Now, it’s gearing up for its first human trials
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to address that disease,” Colin Murdoch, Isomorphic Labs president and Google DeepMind's chief business officer said.
Google’s AI-designed drugs to enter human trials this year
Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling breakthroughs.
Google-backed Isomorphic Labs to launch human trials for AI-designed drugs
Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.
Google DeepMind ready to start human trials of AI-designed drugs; company exec says, ‘We’re getting very close’
Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in pharmaceutical innovation.
Google Ready To Start Human Trials Of Its AI-Designed Drugs
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
Alphabet-owned company to begin human trials for cancer drug developed using AI
Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently preparing to dose the first patients with the AI-engineered drug in clinical trials and is “staffing up” ahead of the trials, Isomorphic Labs president Colin Murdoch said in a recent interview with Fortune.
Google’s Isomorphic Labs “Very Close” To Starting Human Trials For AI-Generated Medicines
Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And his company is on track to put these words into practice. Isomorphic Labs,
Alphabet’s Isomorphic Labs Gets Set for Human Trials of AI-Designed Drugs
Out to make a bigger difference, Alphabet’s Isomorphic Labs is exploring a much more useful application of AI. The Google DeepMind subsidiary is set to begin human trials for AI-designed drugs, marking a big step forward for the medical industry.
Google DeepMind to soon begin human trials of AI-designed drugs
Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a significant leap in pharmaceutical innovation.
Google’s AI-designed cancer drug may soon enter human trials, says DeepMind exec
Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in fields like cancer and immunology using artificial intelligence.
Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is…'
Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...
AOL2d
Google DeepMind has grand ambitions to ‘cure all diseases’ with AI. Now, it’s gearing up for its first human trials - AOL
Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is ...